Home/ Supplements/ Vitamin K/ Vitamin K1 100 mcg

Vitamin K1 100 mcg

product on market Other (e.g. tea bag) Bluebonnet Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Vitamin K1 is essential for the synthesis of proteins required for blood coagulation and bone mineralization. There is strong evidence supporting its role in maintaining skeletal health and proper clotting functions. This supplement provides a standard dose of the nutrient to support these physiological processes.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Vitamin K1 100 mcg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Caplet(s)
Serving Size
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

100 mcg (125% DV)
Within RDA (0.8× RDA) 275 studies (A:9, B:175)

Other Ingredients

Calcium Phosphate Stearic Acid Vegetable Magnesium Stearate Vegetable Cellulose Vegetable Glaze
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Info

Product Information

Directions for Use

Directions: As a dietary supplement, take one caplet daily or as directed by a healthcare practitioner.

Warnings & Precautions

Caution: If you are on blood thinning medication, this product is not recommended.

Formulation Notes

Bluebonnet’s Vitamin K1 100 mcg Caplets provide natural vitamin K1 (phytonadione) in its purest crystalline form.

Made with non GMO ingredients

Vegan

Free of milk, egg, fish, crustacean shellfish, tree nuts, peanuts, wheat and soybeans. Also free of corn, yeast, gluten, barley, rice and sugar.

Bluebonnet’s KOF-K Certification #K-0000700

Additional Information

Available in easy-to-swallow caplets for maximum assimilation and absorption.

0650E

Made with non GMO ingredients

Vegan

K Parve

Gluten free

Metadata

Product Details

UPC / SKU7 43715 00650 8
DSLD Entry Date2018-06-25
Product TypeVitamin
FormOther (e.g. tea bag)
DSLD ID178229
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.